SCHEMBL16645370

SCHEMBL16645370

COC(=O)c1ccc(Nc2ccccc2N)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.50
MAPK1 P28482 2/20 0.49
KDM4E B2RXH2 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ALDH1A1 P00352 2/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
HCAR3 P49019 1/20 0.46
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27168484 0.81 ALDH1A1 (0.47) MAPK1KDM4EL3MBTL1ALDH1A1HPGD
SCHEMBL30777212 0.81 ALDH1A1 (0.47) MAPK1KDM4EL3MBTL1ALDH1A1HPGD
SCHEMBL30061686 0.81 ALDH1A1 (0.47) MAPK1KDM4EL3MBTL1ALDH1A1HPGD
SCHEMBL64414 0.80 HCAR3 (0.71) MAPK1KDM4EL3MBTL1ALDH1A1TSHR
SCHEMBL3499186 0.78 SIRT2 (0.68) HDAC1KDM4EALDH1A1HPGDTSHR
SCHEMBL18131757 0.76 HDAC1 (0.56) HDAC1ALDH1A1HPGDTSHRHDAC3
SCHEMBL31525845 0.76 NPC1 (0.50) MAPK1KDM4EALDH1A1HPGDKMT2A
SCHEMBL13739418 0.76 MAPK1 (0.61) MAPK1KDM4EL3MBTL1ALDH1A1HCAR3
SCHEMBL28382270 0.76 ALDH1A1 (0.43) MAPK1KDM4EL3MBTL1ALDH1A1HPGD
SCHEMBL1702183 0.74 RAB9A (0.49) MAPK1KDM4EL3MBTL1ALDH1A1HCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015052675-A1 SUBSTITUTED DIHYDRO-BENZIMIDAZOLE COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-16 WO disclosed